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Both aging and hormonal status have an eﬀect on pain perception. The goal of this study was to isolate as much as possible the
eﬀect of aging in postmenopausal women. Thirty-two women with regular menstrual cycles (RMW) and 18 postmenopausal
women (PMW) underwent a 2-minute cold pressor test (CPT) to activate DNIC with a series of tonic heat pain stimulations
with a contact thermode to assess ascending pain pathways. We found that this procedure induced much less pain during the ﬁrst
15seconds of stimulation the PMW group (P = 0.03), while the mean thermode pain ratings, pain tolerance, pain threshold, and
DNIC analgesia were similar for both groups (P>0.05). The absence of the peak pain in the PMW was probably due to reduced
function of the myelinated Aδ ﬁbers that naturally occurs with age.
1.Introduction
Aging brings a decline in the majority of sensory modalities
including pain and touch, two sensory modalities involving
Aa n dCﬁ b e r s[ 1]. These two types of primary aﬀerent ﬁbers
carrytouch-(A-β)andpain-relatedinformation(A-δ andC).
Although the observed decline in function of the sensory
system is observed above 65 years of age, there is evidence
that pain-related functions start to decline around middle
age (≈50 years old) [2]. The results obtained by Larivi` ere
et al. showed a decline of function of the endogenous pain
inhibitory system in middle age adults; this decline was
similar to adults above 65 years old. Although these changes
in pain perception can be due to aging, sex hormones could
also be a factor inﬂuencing these changes since women
reach menopause around 50 years of age and sex hormones
levels signiﬁcantly decrease. Although many biopsychosocial
factors inﬂuence pain perception, it has been shown that sex
hormones can inﬂuence many aspects of nociception [3].
This leads to the question: what happens to pain perception
as women reach menopause?
Menopause, deﬁned by the absence of menses for more
than 12 months, usually occurs at about 50 years of
age and results in signiﬁcant changes in sex hormones
levels: decreased progesterone (PRO) and estrogen (EST),
increased luteinizing hormone (LH) and follicle-stimulating
h o r m o n e( F S H ) .A sw ea g e ,w eg e n e r a l l yt e n dt os u ﬀer
from more pain-related pathologies [4], which are often
more prevalent in women [5]. Comparable ﬁndings can
be seen in midlife where postmenopausal women (PMW)
are showing signiﬁcant increases in clinical pain symptoms
[6, 7]. Consequently, the changes in pain perception in this
population of midlife women could be due to the decrease of
sex hormones and/or aging.
We found no previous studies that examined speciﬁc
aspects of nociception and pain perception in PMW com-
pared to women with a regular menstrual cycle (RMW).
Fillingim and Edwards [8] studied the eﬀect of hormonal
replacementtherapy(HRT)onPMWandfoundthatwomen
on HRT had lower pain thresholds than PMW not on HRT.
Although these results conﬂict with what is usually found
in young healthy women, they do seem to indicate that2 Pain Research and Treatment
sex hormones could inﬂuence pain perception in an older
population [8].
In our study, we used a cross-sectional design to examine
pain perception in young PMW in comparison to RMW.
Therefore,thestudy’smaingoalwastoverifytheinﬂuenceof
ageontheascendinganddescendingpainmechanisms,while
controlling for sex hormones levels, a potential confounding
factor. To our knowledge, this has never been done and has
signiﬁcant clinical relevance for a large proportion of the
population.
2. Methods
2.1. Participants. After approval from the hospital ethics
review board, we collected data from 18PMW (mean age
54.5 ± 5.4 years) and 32RMW (mean age 34.3 ± 7.5y e a r s ) .
Subjects were recruited via local publicity and were all
French-speaking women dwelling in the community. Brief
initialphoneinterviewsallowedforthescreeningofpotential
subjects and scheduling them for testing. On the day of
testing, subjects were asked to refrain from smoking (only
four RMW and three PMW self-reported as smokers) and/or
drinking coﬀee one hour before testing. PMW were included
if they met the Society of Obstetricians and Gynaecologists
of Canada criteria for menopause (absence of menses during
the past 12 months). Inclusion criteria for women in the
RMW group were to have a regular menstrual cycle, which
was deﬁned as varying from 26 to 30 days in length. This
criterion was conﬁrmed by verifying menstrual-cycle length
in the month before and after testing (self-reported). The
averagelengthwas28.4±0.8days.NoneoftheRMWhadany
known disease or self-reported hypo/hypertension, or was
taking pain medication. However, ten of the PMW reported
having intermittent low back pain, but none were taking
prescribed medication for this condition. Only three of them
reported taking over-the-counter ibuprofen/acetaminophen
asneeded;whenpresent,themeanintensityoftheirlowback
pain was 4/10 (numerical pain rating score).
All subjects signed an informed consent form and re-
ceived $40 as compensation for taking part in the study. Each
experimental procedure lasted about 90 minutes and took
place at the Centre de Recherche Clinique ´ Etienne-LeBel du
Centre Hospitalier Universitaire de Sherbrooke,S h e r b r o o k e ,
Qu´ ebec, Canada.
2.2. Experimental Design. To control for a potential eﬀect
of sex hormones on pain responses, all RMW were tested
duringdays1to3oftheirmenstrualcycles,whilePMWwere
tested at their convenience. We chose this time frame since
sex hormones levels are at their lowest during menses. This
enabled us to compare pain perception, while both groups
havecomparablesexhormoneslevels.Theﬁrstdayofmenses
was considered as day 1 of the menstrual cycle, which was
obtainedbyself-reportingandconﬁrmedbybloodsampling,
where we observed low levels of PRO, EST, and LH (all levels
where within the normal reference values for this phase of
the menstrual cycle). A qualiﬁed registered nurse took blood
samples for 17β-estradiol, PRO, FSH, LH, and testosterone
dosage, prior to each experimental session.
2.3. Pain Procedures. All subjects underwent the experimen-
tal procedures in the same order (experimental heat pain,
cold-pressor conditioning stimulus, and experimental heat
pain).
2.3.1.Apparatus. Theexperimentalheatpainwasinducedby
a9c m 2 thermode (TSA II, NeuroSensory Analyzer, Medoc
Instruments, North Carolina, USA). During this stimulus,
pain perception was assessed with a computerized visual
analogue scale (COVAS) linked to the thermode, which was
graduated from 0 (absolutely no pain) to 100 (maximum
tolerated pain). This allowed us to determine pain threshold
(PTh), as measured by thermode temperature at which
subjects reported initial pain sensation (visual analogue scale
score: 1/100); pain tolerance (PTol), as measured by the
maximum thermode temperature subjects could tolerate
(visual analogue scale score: 100/100); and mean pain
intensity of the noxious tonic stimulus. The conditioning
stimulus was induced by a cold pressor test (CPT), which
consisted of immersing the right arm (up to the elbow)
in circulating cold water maintained at 12◦C. During the
CPT, subjects were asked to rate their pain intensity every 15
seconds with a numerical pain rating scale ranging from 0 to
100.
2.3.2. Pretest. Subjects were given a pretest for practicing
pain rating with the visual analogue scale and to determine
the temperature to be used for the heat pain test. The pretest
was performed with the thermode applied to the right palm.
For familiarization purposes, subjects were advised that
the thermode temperature would gradually increase from
32◦C to a maximum of 51◦C (rising rate = 0.3◦C/second).
This procedure was repeated twice and the subjects verbally
reported the point at which they actually began feeling pain
(PTh) as well as PTol. On the third test, the thermode was
placed on the volar aspect of the right forearm. Subjects
were given the visual analogue scale and advised that they
would have to start moving the cursor towards the right
(towards the “100” mark) when they started to feel pain
(PTh) and that the cursor had to be at the extreme right (at
the “100” mark) when pain was intolerable (PTol) [9]. This
procedure was repeated until the subject’s pain reports were
consistent between trials. The temperature used during the
tonic experimental heat pain test was the temperature that
the subject had rated pain intensity at 50/100 with the visual
analogue scale during the pretest.
2.3.3. Tonic Experimental Heat Pain Stimulus. The tonic heat
pain test was performed by applying the thermode at a
constant temperature to the anterior (volar) aspect of the left
forearm for two minutes [10]. Before the procedure, subjects
were told that the thermode temperature could increase,
remain stable, or decrease, and that they would have to
evaluate their pain with the visual analogue scale throughout
the test. In fact, after a constant rise (0.3◦C/second) fromPain Research and Treatment 3
the baseline (32◦C) to the predetermined temperature, the
thermode temperature remained constant (mean = 46.1 ±
1.64
◦C—see Table 2 for mean thermode temperature used
for each group) throughout the 120 seconds (ramp and
hold). All subjects were blinded to the temperature used and
to the study’s hypothesis. Two observable events occurred
during the tonic heat pain test [11, 12]. The ﬁrst nociceptive
event was characterized by a sharp but brief increase in
pain intensity. This peak in pain intensity occurred when
the thermode has reached its ﬁxed temperature and lasted
approximately15seconds.Itwaslabeled“peakpain”because
this is the interval in which heat sensitive A-delta ﬁber
nociceptorsdisplaypeakneuronalactivityfollowingconstant
stimulation at suprathreshold levels [13]. Peak pain has
previously been described by Jensen and Petersen [14] using
a similar design and repeated in our laboratories [9]. The
second observable event was the rise in pain intensity that
occurs during the last minute of stimulation. Since this
increase in pain rating occurred at a set temperature, it
clearly describes a temporal summation phenomenon (see
Figure 1), which is known to depend on the summation of
nociceptive inputs from primary aﬀerent C-ﬁbers. Granot
et al. [15] also observed temporal summation eﬀects using
similar tonic heat stimulations. Previous research in our
laboratory has shown that pain perception scores increase
progressively during this tonic heat test, even if the tempera-
ture remains constant [9].
2.3.4. Activation of Diﬀuse Noxious Inhibitory Controls. The
conditioning stimulus (to induce DNIC) was applied to the
opposite arm using the 12◦C CPT. Pain intensity ratings
were measured every 15 seconds during the test. If a subject
removed her arm before the end of the 2 minutes, a pain
intensity score of 100/100 was noted [16, 17]. The CPT
enabled us to activate DNIC and was also used as a diﬀerent
type of tonic pain (cold pain versus heat pain; greater surface
area than the 9cm2 thermode).
2.3.5. Assessment of DNIC Pain Modulation (Analgesia). In
order to measure the analgesic eﬀect of the DNIC activated
by the CPT, the experimental heat pain procedure was
performed immediately after the immersion test using the
same parameters. The amount of pain modulation produced
by the CPT (DNIC eﬃcacy) was calculated as the diﬀerence
in pain score between the mean heat pain after and before
the CPT. A negative score indicated a reduction in pain
perception and therefore analgesia.
2.4. Statistical Analysis. Descriptive statistics are presented
as means and standard deviations (SD) in the text and
as mean and standard error in the ﬁgures. Since our data
were normally distributed, a Student’s t-test was used for
group comparisons of pain perception measurements and to
assessthepresenceofDNICanalgesia,comparingtheaverage
pain score between the ﬁrst and second experimental heat
pain tests (thermode procedure). Afterwards, we compared
the diﬀerence score (mean pain after minus mean pain
before) for both groups, which also allowed us to quantify
Table 1: Sex hormones dosage by group.
Sex Hormones: Mean ± SD
(reference values)
RMW
n = 32
PMW
(n = 18) P value∗
Testosterone (total)
(nmol/L)
1.15 ±0.62
(0.7–2.8)
1.12 ±0.57
(0.7–2.8) 0.86
Progesterone (nmol/L) 4.0 ±4.1
(0.6–4.7)
2.51 ±1.95
(0.3–2.5) 0.15
Estradiol (pmol/L) 151 ±161
(46–607)
97.8 ±66.0
(0–201) 0.18
FSH (IU/L) 6.15 ±4.1
(3.5–12.5)
77.6 ±36.4
(26–135) <0.0001
LH (IU/L) 3.71 ±1.19
(2.4–12.6)
40 ±19.6
(8–59) <0.0001
∗RMW versus PMW.
Reference values for each hormone are reported in parenthesis.
DNIC analgesia. We used a t-test comparing the ﬁrst and
the last pain ratings during the last minute of the thermal
stimulation with the thermode at constant temperature (T60
versus T120) in order to conﬁrm the presence of temporal
summation. Temporal summation was then quantiﬁed by
calculating the mean diﬀerence score between the ﬁrst and
the last pain ratings (pain rating at T120 minus T60)[ 9]. This
enabled us to obtain a delta score, which was compared to
both groups. Peak pain was calculated by obtaining the mean
pain score during this period (ﬁrst 15 seconds of constant
temperature stimulation). A P value of less than 0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Sex Hormones Level. T h em e a nv a l u e sf o re a c hs e x
hormone are illustrated in Table 1. All subjects had sex
hormones within normal levels for each phase according
to the reference values obtained from the biochemistry
laboratory at the Centre Hospitalier Universitaire de Sher-
brooke (http://www.lab.chus.qc.ca/). Sex hormones were
comparable for both groups, except for FSH and LH,
which were higher in the PMW group (a normal endocrine
manifestation of menopause).
3.2. Pain Perception
3.2.1. Heat Pain Threshold and Heat Pain Tolerance. Heat
PTh and PTol, as measured by the thermode temperature
(◦C) at which a subject reports the onset of pain or tolerance,
were similar for both groups (P = 0.46 and 0.29, resp.).
When the elapsed time (sec) before reaching PTh was
evaluated, the PMW took signiﬁcantly longer to report the
onset of pain (43.1±7.69 seconds versus 36.3±13.2 seconds;
P = 0.05), indicating a trend towards higher PTh (sec)
for PMW (see Table 2). Moreover, we found a signiﬁcant
correlation (r = 0.31; P = 0.02) between age and PTh (sec).
No signiﬁcant correlation was found between age and PTol,
mean CPT pain intensity, or PTh (◦C).4 Pain Research and Treatment
0
10
20
30
40
50
60
70
80
90
100
P
a
i
n
i
n
t
e
n
s
i
t
y
0
5
1
0
1
5
2
0
2
5
3
0
3
5
4
0
4
5
5
1
0
1
5
2
0
2
5
3
0
3
5
4
0
4
5
5
0
5
5
6
0
6
5
7
0
7
5
8
0
8
5
9
0
9
5
1
0
0
1
0
5
1
1
0
1
1
5
1
2
0
PMW
RMW
Fixed
temperature
begins
1
2
Peak
pain
period
Temporal summation phase
NS
∗∗∗
∗
Time (seconds)
Pain perception during thermode procedure
Figure 1: Average heat pain (thermode) intensity for all subjects during the “before” session (mean ± SE). (1) The PMW group took longer
to report initial pain and (2) the RMW had much higher peak pain than the PMW. Finally, the temporal summation phase (last minute of
stimulation) was similar for both groups.
Table 2: Group comparison of each pain measurement (mean value ± standard deviation).
Variable RMW (n = 32) (Mean ± SD) PMW (n = 18) (Mean ± SD) P value
Pain threshold (◦C) 42.5 ±3.01 43.2 ±3.84 0.46
Pain threshold (seconds) 36.35 ±13.24 3 .1 ±7.69 0.05
Pain tolerance 47.07 ±1.77 46.7 ±2.49 0.29
Fixed thermode temperature (◦C) 46.3 ±1.04 5 .64 ±2.37 0.18
Peak pain (mean T0 to T15)7 0 .6 ±15.35 7 .44 ±25.76 0.03
Last pain score (T120)7 6 .46 ±19.76 70.66 ±26.20 . 3 8
Thermode (before CPT) (mean T0 to T120)6 9 .4 ±17.08 60.75 ±23.10 . 1 4
Thermode (after CPT) (mean T0 to T120)5 7 .0 ±21.64 8 .89 ±28.64 0.26
CPT mean pain intensity 53.8 ±23.47 4 .3 ±24.8 0.005
TS delta score 9.57 ±14.51 4 .19 ±17.34 0.39
DNIC delta score (T120 minus T60) −12.4 ±15.24 −11.85 ±28.90 . 9 9
3.2.2. Tonic Pain Perception
(1) Cold Pressor Test. For an identical cold pain stimulus,
the PMW reported signiﬁcantly more pain during the CPT,
where the mean pain intensity was 74.3 ± 24.8c o m p a r e dt o
57.44 ±25.76 for the RMW (P = 0.005).
(2) Heat Pain Stimulus (Thermode). We found no signiﬁcant
group diﬀerence in the mean pain ratings during the heat
paintest,wherethemeanintensityforthe120-secondperiod
was 60.75 ± 23.1 for the PMW and 69.4 ± 17.1 for the
RMW (P = 0.14). This was expected since pain intensity was
individually adjusted to a VAS of 50/100. Furthermore, the
thermode temperature used to evoke a pain score of 50/100
was similar for both groups (P = 0.18).
3.2.3. Peak Pain and Temporal Summation
(1) Peak Pain Period. The RMW reported signiﬁcantly
higher pain intensity during the peak pain period (ﬁrst 15
seconds of constant stimulation) compared to the PMW,
where the mean ratings for this period were 70.6 ± 15.3f o r
t h eR M Wv e r s u s5 7 .44 ± 25.76 for the PMW (P = 0.03) (see
Figure 1).
(2) Temporal Summation. Temporal summation did occur
for both groups during the tonic heat pain test, where painPain Research and Treatment 5
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Figure 2: Mean heat pain ratings (thermode) were signiﬁcantly
lower after the CPT. Both groups had comparable changes (de-
crease) in pain intensity ratings following the CPT, indicating com-
parable DNIC analgesia.
intensity at T120 was signiﬁcantly higher than at T60 (all
P<0.05). Furthermore, comparisons of the delta scores
(T120 minus T60) obtained for each group were also similar
(P = 0.39), indicating that both groups had comparable
temporal summation during the tonic heat pain procedure.
Finally, pain ratings at the last point in time (T120)w e r en o t
signiﬁcantly diﬀerent (P = 0.38) (see Figure 1).
3.2.4. DNIC Analgesic Eﬀect on Tonic Heat Pain. Mean pain
ratings for both groups were signiﬁcantly lower during the
thermode procedure following the CPT compared to the
ﬁrst tonic heat pain. This indicates similar DNIC analgesia
for both the RMW and PMW (see Figure 2). This was also
conﬁrmed by comparing the delta scores (mean diﬀerence in
heat pain perception before and after the CPT), which were
similar for both groups (P = 0.99). Detailed results of the
above sections (Section 3.2)a r ep r e s e n t e di nTable 2.
Finally, we reanalyzed the results for the variables where
we found signiﬁcant group diﬀerences (CPT pain, peak
pain, and PTh) with covariance analysis controlling for
FSH and LH (the only two sex hormones that signiﬁcantly
diﬀered between both groups), only the “peak pain” remains
signiﬁcant (P = 0.02).
4. Discussion
In this study, we examined pain responses to diﬀerent ex-
perimental type of nociceptive stimuli in a group of young
PMW and compared the results to nonmenopaused women.
We decided to proceed with the experiment while the RMW
were during their menstrual phase, with the rational being
that sex hormones levels are more comparable to PMW [18];
blood sampling enabled us to assure that both groups had
comparable sex hormones levels for PRO and EST, the main
female sex hormone.
The main ﬁnding of this study is that the PMW showed
an absence of peak pain and a trend towards a delayed PTh
(sec) during the heat pain procedure as clearly illustrated
in Figure 1. Since female sex hormones were comparable
between both groups at time of testing, it suggests that age,
not PRO or EST, is the main factor for these changes in
nociceptive activity. However, since FSH and LH were higher
in the PMW group, we cannot exclude a potential eﬀect of
thesexhormones.However,whenweanalyzedtheresultsfor
the variables where we found signiﬁcant group diﬀerences
(CPT pain, peak pain, and PTh) and statistically controlled
for FSH and LH, only peak pain remained signiﬁcant. This
further supports that the observed group diﬀerence in peak
pain is probably due to age rather than sex hormones.
On a physiological perspective, we think that these
changes in pain perception derive from decreased Aδ-ﬁber
function. Indeed, we and others have previously shown that
the peak pain phase is always present during the tonic heat
pain procedure; this has been demonstrated in young and
middle-aged adults [9, 12, 14].
As Figure 1 clearly shows, the PMW took more time
to reach their PTh (sec) but, most importantly, did not
display the typical “rise and fall” pattern in pain perception
observed during the ﬁrst 15 seconds of constant stimulation.
This diﬀerence in PTh (sec) is neither related to thermode
temperature rate (both groups started at 32◦C with a rising
rate of 0.3◦C/sec) nor to the thermode temperature used
during the constant stimulation period (both groups had
comparable temperatures). Therefore, an age-related factor
would most likely account for these ﬁndings as suggested
by the covariance analysis. Although a literature review
concluded that there were no age-related changes in PTh
or PTol [19], others previously demonstrated that aging
produces an impairment in myelinated nociceptive ﬁbers
(i.e., Aδ ﬁbers) [20], that experimental PTh does increase
withage[4, 21], and that C-ﬁber activity remains intact with
aging [22]. Most importantly, Chakour et al. demonstrated
ad i ﬀerential age-related change in Aδ versus C-ﬁber pain
perception. By blocking Aδ-ﬁber function in a group of
young (20–40 years) and older subjects (>65 years), they
found that both groups had comparable C-ﬁber function.
The thermal PTh (sec), however, was aﬀected only in the
younger group, suggesting decreased Aδ-ﬁber function in
the older subjects [20]. Although we found a signiﬁcant
correlation (r = 0.31; P = 0.02) between age and PTh
(seconds), which indicated that only PTh increases with age,
it only shows a modest association.
Moreover, Tucker et al. [23] also reported a decreased
Aδ-ﬁber function as shown by an increased cutaneous
pain threshold to the transcutaneous neuronal electrical
stimulator. These ﬁndings closely relate to our study, since
the peak pain period during the thermode test is most likely
explained by Aδ-ﬁber activity [13]. To our knowledge, there
is very few relevant literature than these results and the other
studies mentioned supporting such changes in nociception
and aging [24].
We also found that endogenous pain inhibitory mecha-
nisms, more speciﬁcally diﬀuse noxious inhibitory controls
(DNICs), were also equivalent between both groups. This6 Pain Research and Treatment
is somewhat diﬀerent from what is found in the literature,
since previous studies reported changes in DNIC with age
[25, 26]. However, their samples were signiﬁcantly older
than our population of PMW. Furthermore, they compared
their “older” groups to a group of young males and females,
without controlling for menstrual-cycle phase, which is
known to aﬀect DNIC eﬃcacy [27]. The eﬀect of sex
hormones on DNIC eﬃcacy was signiﬁcant only during the
ovulatory phase, a phase which represents only 3 to 5 days of
the complete menstrual cycle, while in the present study, the
data were collected during the menstrual phase of the cycle
[27].
A recent study conducted in our laboratories has also
shown a decrease in DNIC eﬃcacy after the age of 45 [2].
These results might be accounted for, in part, by the fact that
ad i ﬀerent experimental design was used and that sex hor-
mones levels or menstrual-cycle phase was not controlled.
Furthermore, although the PMW and RMW in our sample
show comparable DNIC analgesia, the PMW reported more
pain during the conditioning stimuli (cold pressor test) (see
Section 3.2.2 (1)), yet they showed similar DNIC analgesia.
This could suggest that the PMW would have had lower
DNIC analgesia if they had lower pain score during the
conditioning stimulus. However, we did not observe any
signiﬁcant interaction between DNIC eﬃcacy (delta scores)
and CPT pain intensity used as a covariable (P = 0.60).
This observation strongly suggests that DNIC analgesia is
therefore comparable in both groups. Consequently, we
think that our PMW were probably too young to allow us
to observe any age diﬀerence in DNIC.
The results regarding tonic painful procedures and PTol
suggest that PMW have comparable C-ﬁber nociceptive
activity. Although our sample of PMW reported greater pain
ratingsduring theCPT,weobserved nosigniﬁcantdiﬀerence
in temporal summation of heat pain, an event mostly related
toC-ﬁbers[15].ThefactthatPMWhadhigherpainintensity
ratings during the CPT, but not elsewhere, might be related
to the greater aﬀective component of this test. The cold
pressor test has been shown to induce higher estimates
of unpleasantness, and thus may better mimic clinical
pain [28], which 10 women in the PMW group reported.
Furthermore, the fact that PMW had higher pain intensity
ratingsduringtheCPTcouldalsobeexplainedbythespeciﬁc
eﬀect of hormonal changes on mood by menopause, where
PMW are at higher risk of depression [29]; depression is
known to negatively inﬂuence pain perception [30]. Also,
since the cold pressor test pain is mainly related to the
activity of C-ﬁbers [31], it may well be a separate eﬀect
between a-delta and c-ﬁbers. Finally, aging has previously
been demonstrated to be related to a reduction of cutaneous
pain but an augmentation of deep pain [32]. Since the
thermode produces a cutaneous pain and that the cold
pressortestproducesdeeppain,itmayexplaintheapparently
contradictory results.
These results have important clinical implications. First,
it shows that quantitative sensory testing, such as the heat
pain procedure, brings useful information for the detection
of impairments in the peripheral nervous system. Moreover,
since our test seems to discriminate Aδ and C-ﬁber activity,
it could serve as an objective criterion for measuring the
severity of pain-related disorders, such as neuropathic pain.
Our study has potential limitations. First, we know
that LH and FSH levels were higher in the PMW group.
Hence, we cannot ignore the possibility that the observed
diﬀerences in LH and FSH are indeed responsible in the
observed pain responses rather than age. There is, however,
no way of controlling for these two speciﬁc sex hormones. As
mentionedintheintroduction,thehigherLHandFSHlevels
are natural manifestations of menopause. Moreover, past
studies on pain perception and sex hormones did not reveal
that LH or FSH had any eﬀe c to np a i np e r c e p t i o n[ 18, 33].
Finally,thefactthat10PMWreportedlower-backpaincould
be a potential confounding factor. In fact, studies show that
low back pain can sensitize [34] the central nervous system
whichcouldthenexplainwhyPMWwomenhadgreaterpain
during the cold pressor test. However, this could not explain
why PMW had lower pain ratings (peak pain) during the 2-
minute heat pain test with the thermode. However, since low
back pain symptoms are frequent in the general population,
it adds to the external validity, since the prevalence of painful
conditions (such as low back pain) usually increases with age
[4].
The age eﬀects we observed are probably not limited to
women.Sincetherewasnocontrolgroupofmen,itwouldbe
imprudent to imply that the external validity of our results
applies to men. More research is needed to address this
question.
In conclusion, age seems to be the main factor inﬂu-
encing changes in tonic pain perception in our group of
midlife PMW. The absence of the peak pain in the PMW
was probably due to a reduction of function in myelinated
Aδ ﬁbers that naturally occurs with age. Interestingly, these
changes in pain perception occurred as early as 50 years
old, which is congruent with recent literature [2]. These
pain-related changes in postmenopausal women clearly
demonstrate the importance of studying nociception and
endogenous pain modulation in this population.
Acknowledgments
This study received funding from the Canadian Institute of
Health Research (CIHR), the Fonds de Recherche en Sant´ e
du Qu´ ebec (FRSQ), and the Institut Robert-Sauv´ ee nS a n t ´ ee t
S´ ecurit´ ea uT r a v a i l(IRSST). Yannick Tousignant-Laﬂamme
and Serge Marchand are supported members of the Centre
de Recherche Clinique ´ Etienne-Le Bel du Centre Hospitalier
Universitaire de Sherbrooke.
References
[1] M. M. Wickremaratchi and J. G. Llewelyn, “Eﬀects of ageing
on touch,” Postgraduate Medical Journal, vol. 82, no. 967, pp.
301–304, 2006.
[2] M.Lariviere,P .Goﬀaux,S.Marchand,andN.Julien,“Changes
in pain perception and descending inhibitory controls start at
middle age in healthy adults,” Clinical Journal of Pain, vol. 23,
no. 6, pp. 506–510, 2007.Pain Research and Treatment 7
[3] R. B. Fillingim, C. D. King, M. C. Ribeiro-Dasilva, B. Rahim-
Williams III, and R. J. L. Sex, “Sex, gender, and pain: a review
of recent clinical and experimental ﬁndings,” Journal of Pain,
vol. 10, no. 5, pp. 447–485, 2009.
[4] S. J. Gibson and M. Farrell, “A review of age diﬀerences in the
neurophysiologyofnociceptionandtheperceptualexperience
of pain,” Clinical Journal of Pain, vol. 20, no. 4, pp. 227–239,
2004.
[5] S. G. Leveille, Y. Zhang, W. McMullen, M. Kelly-Hayes, and
D. T. Felson, “Sex diﬀerences in musculoskeletal pain in older
adults,” Pain, vol. 116, no. 3, pp. 332–338, 2005.
[ 6 ]S .A .D u g a n ,L .H .P o w e l l ,H .M .K r a v i t z ,S .A .E v e r s o n
Rose, K. Karavolos, and J. Luborsky, “Musculoskeletal pain
and menopausal status,” Clinical Journal of Pain, vol. 22, no.
4, pp. 325–331, 2006.
[7] E. W. Freeman, M. D. Sammel, H. Lin et al., “Symptoms
associated with menopausal transition and reproductive hor-
mones in midlife women,” ObstetricsandGynecology, vol. 110,
no. 2, part 1, pp. 230–240, 2007.
[ 8 ]R .B .F i l l i n g i ma n dR .R .E d w a r d s ,“ T h ea s s o c i a t i o no fh o r -
mone replacement therapy with experimental pain responses
in postmenopausal women,” Pain, vol. 92, no. 1-2, pp. 229–
234, 2001.
[9] Y. Tousignant-Laﬂamme, S. Page, P. Goﬀaux, and S. Marc-
hand, “An experimental model to measure excitatory and
inhibitory pain mechanisms in humans,” Brain Research, vol.
1230, pp. 73–79, 2008.
[10] W.J.Redmond,P.Goﬀaux,S.Potvin,andS.Marchand,“Anal-
gesic and antihyperalgesic eﬀects of nabilone on experimental
heat pain,” Current Medical Research and Opinion, vol. 24, no.
4, pp. 1017–1024, 2008.
[11] P. Goﬀaux, W. J. Redmond, P. Rainville, and S. Marchand,
“Descendinganalgesia—whenthespineechoeswhatthebrain
expects,” Pain, vol. 130, no. 1-2, pp. 137–143, 2007.
[12] S. Potvin, E. Stip, A. Tempier et al., “Pain perception
in schizophrenia: no changes in diﬀuse noxious inhibitory
controls (DNIC) but a lack of pain sensitization,” Journal of
Psychiatric Research, vol. 42, no. 12, pp. 1010–1016, 2008.
[13] R. D. Treede, R. A. Meyer, S. N. Raja, and J. N. Campbell,
“Evidence for two diﬀerent heat transduction mechanisms
in nociceptive primary aﬀerents innervating monkey skin,”
Journal of Physiology, vol. 483, no. 3, pp. 747–758, 1995.
[14] M. T. Jensen and K. L. Petersen, “Gender diﬀerences in pain
and secondary hyperalgesia after heat/capsaicin sensitization
in healthy volunteers,” Journal of Pain, vol. 7, no. 3, pp. 211–
217, 2006.
[ 1 5 ]M .G r a n o t ,Y .G r a n o v s k y ,E .S p r e c h e r ,R .R .N i r ,a n dD .
Yarnitsky, “Contact heat-evoked temporal summation: tonic
versus repetitive-phasic stimulation,” Pain, vol. 122, no. 3, pp.
295–305, 2006.
[16] N. Julien, P. Goﬀaux, P. Arsenault, and S. Marchand,
“Widespread pain in ﬁbromyalgia is related to a deﬁcit of
endogenous pain inhibition,” Pain, vol. 114, no. 1-2, pp. 295–
302, 2005.
[17] S. Marchand and P. Arsenault, “Spatial summation for pain
perception: interaction of inhibitory and excitatory mecha-
nisms,” Pain, vol. 95, no. 3, pp. 201–206, 2002.
[18] R. B. Fillingim and T. J. Ness, “Sex-related hormonal inﬂu-
ences on pain and analgesic responses,” Neuroscience and
Biobehavioral Reviews, vol. 24, no. 4, pp. 485–501, 2000.
[19] S. W. Harkins, “Geriatric pain. Pain perceptions in the old,”
Clinics in Geriatric Medicine, vol. 12, no. 3, pp. 435–459, 1996.
[20] M. C. Chakour, S. J. Gibson, M. Bradbeer, and R. D.
Helme, “The eﬀect of age on A Δ- and C-ﬁbre thermal pain
perception,” Pain, vol. 64, no. 1, pp. 143–152, 1996.
[21] S. J. Gibson, “Older people’s pain,” Pain: Clinical Updates, vol.
14, no. 3, pp. 1–4, 2006.
[22] N. Parkhouse and P. M. Le Quesne, “Quantitative objective
assessment of peripheral nociceptive C ﬁbre function,” Journal
of Neurology Neurosurgery and Psychiatry,v o l .5 1 ,n o .1 ,p p .
28–34, 1988.
[ 2 3 ]M .A .T u c k e r ,M .F .A n d r e w ,S .J .O g l e ,a n dJ .G .D a v i s o n ,
“Age-associated change in pain threshold measured by tran-
scutaneous neuronal electrical stimulation,” Age and Ageing,
vol. 18, no. 4, pp. 241–246, 1989.
[24] L. Gagliese and R. Melzack, “Pain in the elderly,” in Wall
and Melzack’s Textbook of Pain,S .B .M c M a h o na n dM .
Kolzenburg, Eds., pp. 1169–1179, Elsevier, London, UK, 2006.
[25] R. R. Edwards and R. B. Fillingim, “Eﬀects of age on temporal
summationandhabituationofthermalpain:clinicalrelevance
inhealthyolderandyoungeradults,”JournalofPain,vol.2,no.
6, pp. 307–317, 2001.
[26] R. R. Edwards, R. B. Fillingim, and T. J. Ness, “Age-related
diﬀerences in endogenous pain modulation: a comparison
of diﬀuse noxious inhibitory controls in healthy older and
younger adults,” Pain, vol. 101, no. 1-2, pp. 155–165, 2003.
[27] Y. Tousignant-Laﬂamme and S. Marchand, “Excitatory and
inhibitory pain mechanisms during the menstrual cycle in
healthy women,” Pain, vol. 146, no. 1-2, pp. 47–55, 2009.
[28] P. Rainville, J. S. Feine, M. C. Bushnell, and G. H. Duncan, “A
psychophysical comparison of sensory and aﬀective responses
to four modalities of experimental pain,” Somatosensory and
Motor Research, vol. 9, no. 4, pp. 265–277, 1992.
[29] A. H. Clayton and P. T. Ninan, “Depression or menopause?
Presentation and management of major depressive disorder in
perimenopausal and postmenopausal women,” Primary Care
Companion to the Journal of Clinical Psychiatry,v o l .1 2 ,n o .1 ,
2010.
[30] E. Normand, S. Potvin, I. Gaumond, G. Cloutier, J. F. Corbin,
and S. Marchand, “Pain inhibition is deﬁcient in chronic
widespread pain but normal in major depressive disorder,”
Journal of Clinical Psychiatry, vol. 72, no. 2, pp. 219–224, 2011.
[31] H. Fruhstorfer and U. Lindblom, “Vascular participation in
deep cold pain,” Pain, vol. 17, no. 3, pp. 235–241, 1983.
[32] K. M. Woodrow, G. D. Friedman, A. B. Siegelaub, and M.
F. Collen, “Pain tolerance: diﬀerences according to age, sex
and race,” Psychosomatic Medicine, vol. 34, no. 6, pp. 548–556,
1972.
[33] V. T. Martin, “Ovarian hormones and pain response: a review
of clinical and basic science studies,” Gender Medicine, vol. 6,
no. 2, pp. 168–192, 2009.
[34] T. Giesecke, R. H. Gracely, M. A. Grant et al., “Evidence of
augmented central pain processing in idiopathic chronic low
back pain,” Arthritis and Rheumatism, vol. 50, no. 2, pp. 613–
623, 2004.